Insider trading and institutional ownership changes related to Madrigal Pharmaceuticals were disclosed to the SEC.
1 report, 1 independent
Updated Sep 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Insider trading and institutional ownership changes related to Madrigal Pharmaceuticals were disclosed to the SEC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
SEC
Slovak company
Related events
- HCW Biologics Inc. filed disclosures with the SEC and its shares are listed on Nasdaq.
- Bristol Myers Squibb filed with the SEC on May 28, 2026, regarding increased institutional ownership and share purchases.
- Surgery Partners and Fifth Third Bancorp announced increased holdings in company stock, requiring filing with the SEC on September 8, 2026.
- Orchestra BioMed Holdings, Inc. is listed on Nasdaq, and various investment firms including BlackRock, UBS AM, and others have purchased new stakes in the company.
- Pulse Biosciences disclosed stock transactions via a legal filing with the SEC.